Inter-laboratory Quality Assurance for Neonatal G6PD Screening
(Survey No: 92-01)


   Sample sent onJanuary 13, 2003   Report deadline: January 27, 2003

   Total screening unit11      Total reports returned9


Sample No.

A1

A2

A3

 B1 B2 C1 C2 C4 C5

G6PD activity*

1

8.3 (-)

2.5 (-)

2.5 (-)

4.3 (-)

3.63 (-)

6.5

2

6.8 (-)

2.2 (-)

2.4 (-)

2.6 (-)

2.52 (+)

6.1

3

7.8 (-)

2.9 (-)

2.7 (-)

3.6 (-)

3.59 (-)

7.2

4

7.7 (-)

2.7 (-)

2.9 (-)

3.6 (-)

2.96 (-)

7.2

5

8.0 (-)

2.4 (-)

2.3 (-)

3.9 (-)

3.34 (-)

6.5

6

7.3 (-)

2.7 (-)

2.2 (-)

3.8 (-)

5.05 (-)

7.2

7

7.2 (-)

2.5 (-)

2.2 (-)

2.8 (-)

2.84 (-)

6.5

8

6.9 (-)

2.1 (+)

2.2 ()

3.5 ()

2.71 ()

6.1

9

7.2 (-)

2.5 (-)

2.3 (-)

3.9 (-)

2.29 (+)

6.5

10

2.6 (+)

0.7 (+)

0.8 (+)

0.5 (+)

1.05 (+)

1.5

                                 *  G6PDU/g Hb, determined at Clin. Biochem. Res. Lab, VGH-Taipei

                         ** The positive result assigned by the participants are indicated by red color in the table.


Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :

updated : 20 Dec, 2004

[Home]


HOME